Agile Therapeutics, Inc. (AGRX)
Aug 26, 2024 - AGRX was delisted (reason: acquired by Insud Pharma)
1.510
0.00 (0.00%)
Inactive · Last trade price on Aug 26, 2024
Agile Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
Revenue Revenue Growth | 5.58 | 5.72 | 3.61 | 6.66 | 5.5 | 3.81 | 4 | 3 | 2.13 | 1.76 | 1.51 | 1.29 | 1.19 | 0.12 | 0.75 | - | - | - | - | - |
Revenue Growth | 1.33% | 49.91% | -9.56% | 121.92% | 158.84% | 116.52% | 163.94% | 133.26% | 79.41% | 1418.10% | 102.14% | - | - | - | - | - | - | - | - | - |
Gross Profit Gross Profit Growth | 4.08 | 4.04 | 1.42 | 4.18 | 3.2 | 1.81 | 2.34 | 1.58 | -0.11 | 0.23 | -4.19 | -1.42 | 0.04 | -1.05 | 0.47 | - | - | - | - | - |
Operating Income Operating Income Growth | -2.75 | -2.76 | -4.05 | -4 | -5.13 | -6.71 | -6.88 | -7.59 | -11.4 | -15.57 | -22.36 | -15.77 | -16.65 | -16.22 | -16.74 | -14.66 | -10.04 | -7.62 | -6.11 | -4.5 |
Net Income Net Income Growth | -11.87 | 1.28 | -4.47 | -0.8 | -3.81 | -5.39 | -3.93 | -5.93 | -5.17 | -10.39 | -19.53 | -16.77 | -17.64 | -17.13 | -17.62 | -15.52 | -10.83 | -7.88 | -6.02 | -4.43 |
Earnings Per Share EPS Growth | -1.73 | 0.28 | -1.51 | -0.27 | -2.15 | -5.91 | -4.77 | -8.01 | -57.29 | -166.68 | -331.25 | -357.77 | -397.70 | -390.93 | -402.98 | -360.00 | -248.24 | -205.68 | -192.49 | -165.34 |
EPS Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
Cash & Investments Cash & Investments Growth | 2.85 | 2.62 | 2.56 | 2.87 | 2.79 | 4.43 | 5.25 | 6.15 | 13.03 | 3.74 | 19.14 | 14.74 | 31.12 | 40.11 | 54.47 | 71.91 | 87.24 | 93.93 | 34.48 | 18.37 |
Total Debt Total Debt Growth | 0.29 | 0.38 | 2.17 | 2.52 | 2.69 | 2.22 | 2.21 | 2.15 | 13.5 | 13.19 | 17.79 | 16.47 | 16.11 | 15.74 | 16.52 | 16.11 | 15.86 | 15.6 | 0.17 | 0.21 |
Net Cash (Debt) Net Cash Growth | 2.56 | 2.24 | 0.39 | 0.36 | 0.09 | 2.21 | 3.04 | 4 | -0.47 | -9.45 | 1.35 | -1.74 | 15.01 | 24.37 | 37.95 | 55.79 | 71.38 | 78.33 | 34.31 | 18.16 |
Net Cash Growth | 2712.09% | 1.08% | -87.31% | -91.10% | - | - | 124.65% | - | - | - | -96.44% | - | -78.97% | -68.89% | 10.63% | 207.26% | 590.51% | 594.68% | 336.98% | 64.76% |
Net Cash Per Share Net Cash Per Share Growth | 0.37 | 0.48 | 0.13 | 0.12 | 0.05 | 2.43 | 3.68 | 5.41 | -5.23 | -151.64 | 22.91 | -37.03 | 338.47 | 556.20 | 867.99 | 1277.46 | 1636.70 | 2043.65 | 1096.77 | 677.41 |
| Fiscal Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
Operating Cash Flow Operating Cash Flow Growth | 0.23 | -2.48 | 0.17 | 0.37 | -8.52 | -1.6 | -1.56 | -16.7 | -2.93 | -14.75 | -16.62 | -18.58 | -15.34 | -14.67 | -17.34 | -15.32 | -6.77 | -7.88 | -3.27 | -5.08 |
Capital Expenditures CapEx Growth | - | - | - | - | - | - | - | - | -0.01 | -0.13 | -0.06 | -0.07 | -0.08 | -0.07 | -0.06 | -0.07 | -0.06 | -0.16 | -0.07 | -0.03 |
Free Cash Flow Free Cash Flow Growth | 0.23 | -2.48 | 0.17 | 0.37 | -8.52 | -1.6 | -1.56 | -16.7 | -2.94 | -14.88 | -16.67 | -18.65 | -15.41 | -14.74 | -17.4 | -15.39 | -6.82 | -8.05 | -3.34 | -5.11 |
Free Cash Flow Growth | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Fiscal Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
Gross Margin | 73.17% | 70.61% | 39.37% | 62.82% | 58.08% | 47.47% | 58.63% | 52.53% | -4.94% | 13.29% | -276.55% | -110.64% | 3.38% | - | 62.35% | - | - | - | - | - |
Operating Margin | -49.25% | -48.23% | -112.12% | -60.04% | -93.15% | -175.92% | -172.12% | -252.70% | -536.12% | -884.33% | -1476.75% | -1225.64% | -1405.15% | -13984.48% | -2235.11% | - | - | - | - | - |
Pretax Margin | -212.91% | 22.46% | -123.69% | -11.99% | -69.22% | -141.36% | -98.37% | -197.53% | -243.09% | -855.20% | -1289.96% | -1303.19% | -1488.35% | -14765.52% | -2352.47% | - | - | - | - | - |
Profit Margin | -212.91% | 22.46% | -123.69% | -11.99% | -69.22% | -141.36% | -98.37% | -197.53% | -243.09% | -589.72% | -1289.96% | -1303.19% | -1488.35% | -14765.52% | -2352.47% | - | - | - | - | - |
FCF Margin | 4.18% | -43.32% | 4.76% | 5.48% | -154.81% | -41.83% | -39.01% | -556.40% | -138.33% | -844.80% | -1101.25% | -1448.72% | -1300.76% | -12706.03% | -2322.96% | - | - | - | - | - |
| Fiscal Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 | Jun '21 Jun 30, 2021 | Mar '21 Mar 31, 2021 | Dec '20 Dec 31, 2020 | Sep '20 Sep 30, 2020 | Jun '20 Jun 30, 2020 | Mar '20 Mar 31, 2020 | Dec '19 Dec 31, 2019 | Sep '19 Sep 30, 2019 |
PS Ratio | 0.45 | 0.11 | 0.25 | 0.23 | 0.19 | 0.81 | 0.85 | 1.38 | 2.15 | 4.91 | 14.44 | 26.78 | 57.26 | 210.71 | 335.03 | - | - | - | - | - |